探讨静脉注射用人免疫球蛋白联合重组人干扰素α-2b注射液治疗手足口病(HFMD)患儿的临床效果  被引量:1

Objective To Investigate the Clinical Effect of Intravenous Intravenous Immunoglobulin combined with Recombinant Human Interferon Alpha-2b Injection in the Treatment of Children with Hand,Foot and Mouth Disease(HFMD)

在线阅读下载全文

作  者:曾柳凤 ZENG Liu-feng(Dongguan Humen Hospital,Dongguan,Guangdong 523900)

机构地区:[1]东莞市虎门医院,广东东莞523900

出  处:《智慧健康》2020年第22期123-124,129,共3页Smart Healthcare

摘  要:目的探究手足口病(HFMD)患儿治疗中静脉注射用人免疫球蛋白联合重组人干扰素α-2b注射液的应用效果。方法自我院2017年1月至2019年12月收治的手足口病患儿中抽选120例为研究对象,通过系统法分为对照组和研究组,分别使用常规治疗和静脉注射用人免疫球蛋白联合重组人干扰素α-2b注射液治疗,对比两组患儿治疗后症状消失时间以及治疗效果。结果研究组患儿治疗后退热时间、食欲改善时间、精神症状改善时间、口腔疼痛缓解时间以及皮疹消退时间与对照组相比均较少,两组患者治疗效果对比来看,研究组高与对照组,分别为95.00%和80.00%,差异呈统计学意义(P<0.05)。结论手足口病(HFMD)患儿治疗中静脉注射用人免疫球蛋白联合重组人干扰素α-2b注射液的应用嫩能够有效促进患儿症状改善,加快治疗速度,缩短治疗时间,值得全方位推广应用。Objective To explore the effect of intravenous immunoglobulin combined with recombinant human interferon alpha-2b injection in the treatment of children with hand,foot and mouth disease(hfmd).Methods From January 2017 to December 2019,120 of the children with hand,foot and mouth disease were selected as the study subjects.the system method was divided into the control group and the study group,respectively,using routine treatment and intravenous administration of human immunoglobulin combined with recombinant human interferonα-2b injection to compare the time of symptom disappearance and the therapeutic effect after treatment in the two groups.Results Compared with the control group,the patients in the study group had less antipyretic time,appetite improvement time,mental symptom improvement time,oral pain relief time and skin rash regression time.Conclusion The treatment of children with hand,foot and mouth disease(hfmd)with intravenous injection of human immunoglobulin combined with recombinant human interferon alpha-2b injection can effectively promote the improvement of symptoms of children,accelerate the treatment speed and shorten the treatment time,which is worthy of all-round application.

关 键 词:手足口病(HFMD)患儿 静脉注射用人免疫球蛋白 重组人干扰素α-2b注射液 

分 类 号:R725.1[医药卫生—儿科]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象